Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 26, 2021
Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in ArgentinaEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Brain : a Journal of Neurology|June 10, 2026
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosisCarmen Tur, Silvia Susin-Calle, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2024
Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapiesRené Carvajal, Breogán Rodríguez-Acevedo, Lorena García-Vasco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 27, 2022
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in ArgentinaJuan I Rojas, Agustín Pappolla, Liliana Patrucco, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis DiagnosisManuel Comabella, Agustín Pappolla, Enric Monreal, et al.
Annals of Neurology|July 6, 2026
Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance OutcomesEvy M Reinders, Ariadna Masot-Llima, Susana Otero-Romero, et al.
Multiple Sclerosis and Related Disorders|January 17, 2021
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 27, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, et al.
Neurological Research|October 2, 2022
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEMZanga Gisela, Portinari Carla, Barber Josefina, et al.
Journal of the Neurological Sciences|May 26, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registryMaria A Piedrabuena, Jorge Correale, Marcela Fiol, et al.
Pageof 5